Clinical Trials Directory

Trials / Completed

CompletedNCT04989543

Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)

Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)(CEBAM)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Larena SAS · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

It aims to determine and compare the degree of vaginal bacterial alpha diversity in the absence (healthy population) or presence of bacterial vaginosis (pathological population).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTvaginal swabsNugent score: Vaginal swabbing with the dry swab, make two smears on slides. Cytobacteriological examination: swabbing at the exo-endocrine junction using the swab Evaluation of the vaginal microbiota: swabbing at the exo-endocrine junction using the swab

Timeline

Start date
2020-11-24
Primary completion
2020-12-03
Completion
2021-11-03
First posted
2021-08-04
Last updated
2021-12-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04989543. Inclusion in this directory is not an endorsement.